OVEREXPRESSION OF P53 TUMOR-SUPPRESSOR PROTEIN IN POROKERATOSIS

被引:69
|
作者
MAGEE, JW
MCCALMONT, TH
LEBOIT, PE
机构
[1] UNIV CALIF SAN FRANCISCO,DEPT PATHOL,SAN FRANCISCO,CA 94143
[2] UNIV CALIF SAN FRANCISCO,DEPT DERMATOL,SAN FRANCISCO,CA 94143
关键词
D O I
10.1001/archderm.130.2.187
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: p53 is a tumor suppressor nucleoprotein. Mutations of the p53 gene have been found in a variety of malignant neoplasms. Wild-type p53 has a short half-life, possibly only 20 to 30 minutes, and is not present in the nucleus at levels that are detectable with routine immunohistochemical techniques. Mutant p53 has a longer half-life, and is readily detectable with immunoperoxidase staining. Results: We studied 17 specimens from patients with either porokeratosis of Mibelli or actinic porokeratosis, using immunoperoxidase staining with an antibody directed against the p53. There was staining of lesional keratinocyte nuclei in 16 of 17 specimens, limited in most cases to the zone between carnoid lamellae. Staining for proliferating cell nuclear antigen was increased above background levels in only six of 13 specimens. Conclusions: The finding of p53 immunoperoxidase staining in porokeratosis suggests genetic mutation, as occurs in other cutaneous keratinocytic neoplasms, and the lack of corresponding proliferating cell nuclear antigen expression in many specimens indicates that p53 overexpression is not simply a reflection of increased cellular proliferation.
引用
收藏
页码:187 / 190
页数:4
相关论文
共 50 条
  • [1] THE TUMOR-SUPPRESSOR P53
    DONEHOWER, LA
    BRADLEY, A
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1155 (02) : 181 - 205
  • [2] OVEREXPRESSION OF THE TUMOR-SUPPRESSOR GENE P53 IS NOT IMPLICATED IN NEUROENDOCRINE TUMOR CARCINOGENESIS
    WANG, DG
    JOHNSTON, CF
    ANDERSON, N
    SLOAN, JM
    BUCHANAN, KD
    [J]. JOURNAL OF PATHOLOGY, 1995, 175 (04): : 397 - 401
  • [3] P53 - A TUMOR-SUPPRESSOR GENE
    WUSTROW, TPU
    [J]. HNO, 1993, 41 (05) : A12 - A13
  • [4] THE P53 TUMOR-SUPPRESSOR GENE
    LEVINE, AJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (20): : 1350 - 1352
  • [5] THE P53 TUMOR-SUPPRESSOR GENE
    LEVINE, AJ
    CHANG, AW
    DITTMER, D
    NOTTERMAN, DA
    SILVER, A
    THORN, K
    WELSH, D
    WU, M
    [J]. JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1994, 123 (06): : 817 - 823
  • [6] POSTTRANSLATIONAL REGULATION OF P53 TUMOR-SUPPRESSOR PROTEIN FUNCTION
    MAXWELL, SA
    ROTH, JA
    [J]. CRITICAL REVIEWS IN ONCOGENESIS, 1994, 5 (01): : 23 - 57
  • [7] P53 TUMOR-SUPPRESSOR GENE-MUTATIONS AND PROTEIN OVEREXPRESSION IN PANCREATIC DUCTAL ADENOCARCINOMAS
    RALL, CJN
    GRAEMECOOKE, F
    BEAUCHAMP, R
    YANDELL, DW
    RUSTGI, AK
    [J]. GASTROENTEROLOGY, 1994, 106 (04) : A431 - A431
  • [8] The role of p53 tumor-suppressor protein in apoptosis and cancerogenesis
    Maximov, G. K.
    Maximov, K. G.
    [J]. BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2008, 22 (02) : 664 - 668
  • [9] MUTANT P53 TUMOR-SUPPRESSOR PROTEIN AS AN IMMUNOTHERAPEUTIC TARGET
    CARBONE, DP
    YANUCK, M
    WIEDENFELD, E
    CIERNIK, F
    FERNANDEZVINA, M
    PENDLETON, CD
    TSUKUI, T
    MINNA, JD
    BERZOFSKY, JA
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 165 - 165
  • [10] OVEREXPRESSION OF THE P53 TUMOR-SUPPRESSOR GENE IN MYELOID LEUKEMIC-CELLS
    EHINGER, M
    OLSSON, I
    GULLBERG, U
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 167 - 167